Treatment of Aplasia Cutis Congenita on Scalp using Hyalomatix$^{(R)}$: A Case Report

하이알로매트릭스를 이용한, 두개골결손을 동반한 선천성피부무형성증의 치료: 1례 보고

  • Rhee, Suk-Hyun (Institute for Human Tissue Restoration, Department of Plastic and Reconstructive Surgery, Kangnam Severance Hospital, Yonsei University College of Medicine) ;
  • Hong, Jong-Won (Institute for Human Tissue Restoration, Department of Plastic and Reconstructive Surgery, Kangnam Severance Hospital, Yonsei University College of Medicine) ;
  • Roh, Tai-Suk (Institute for Human Tissue Restoration, Department of Plastic and Reconstructive Surgery, Kangnam Severance Hospital, Yonsei University College of Medicine) ;
  • Kim, Young-Seok (Institute for Human Tissue Restoration, Department of Plastic and Reconstructive Surgery, Kangnam Severance Hospital, Yonsei University College of Medicine) ;
  • Rah, Dong-Kyun (Institute for Human Tissue Restoration, Department of Plastic and Reconstructive Surgery, Kangnam Severance Hospital, Yonsei University College of Medicine)
  • 이석현 (연세대학교 의과대학 강남세브란스병원 성형외과학교실.인체조직복원 연구소) ;
  • 홍종원 (연세대학교 의과대학 강남세브란스병원 성형외과학교실.인체조직복원 연구소) ;
  • 노태석 (연세대학교 의과대학 강남세브란스병원 성형외과학교실.인체조직복원 연구소) ;
  • 김영석 (연세대학교 의과대학 강남세브란스병원 성형외과학교실.인체조직복원 연구소) ;
  • 나동균 (연세대학교 의과대학 강남세브란스병원 성형외과학교실.인체조직복원 연구소)
  • Received : 2010.03.10
  • Accepted : 2010.05.25
  • Published : 2010.07.10

Abstract

Purpose: Aplasia Cutis Congenita (ACC) is a rare disease characterized by the focal defect of the skin at birth, frequently involving scalp, but it may affect any region of the body. There are no etiology known but some conditions such as intrauterine vascular ischemia, amniotic adherences and viral infections are associated. The ideal treatment for the ACC is not known. Superficial and relatively small sized defects (< $3{\times}5\;cm$) may heal spontaneously and large defects related with risks of infection and bleeding may require aggressive surgical treatment. Hyalomatrix$^{(R)}$ is a bilayer of an esterified hyaluronan scaffold beneath a silicone membrane. It has been used as a temporary dermal substitute to cover deep thickness skin defect and has physiological functions derive from the structural role in extracellular matrix and interaction with cell surface receptor. This material has been used for the wound bed pre-treatment for skin graft to follow and especially in uncooperative patient, like a newborn, this could be a efficient and aseptic way of promoting granulation without daily irritative wound care. For this reason, using Hyalomatrix$^{(R)}$ for the treatment of ACC was preferred in this paper. Methods: We report a case of a newborn with ACC of the vertex scalp and non-ossified partial skull defect. The large sized skin and skull defect ($6{\times}6\;cm$) was found with intact dura mater. No other complications such as bleeding or abnormal neurologic sign were accompanied. Escharectomy was performed and Hyalomatrix$^{(R)}$ was applied for the protection and the induction of acute wound healing for 3 months before the split-thickness skin graft. During the 3 months period, the dressing was renewed in aseptic technique for every 3 weeks. The skin graft was achieved on the healthy granulation bed. Results: The operative procedure was uneventful without necessity of blood transfusion. Postoperative physical examination revealed no additional abnormalities. Regular wound management was performed in out-patient clinic and the grafted skin was taken completely. No other problems developed during follow-up. Conclusion: Hyalomatrix$^{(R)}$ provides protective and favorable environment for wound healing. The combination of the use of Hyalomatrix$^{(R)}$ and the skin graft will be a good alternative for the ACC patients with relatively large defect on vertex.

Keywords

References

  1. Santos de Oliveira R, Barros Juca CE, Lopes Lins-Neto A, Aparecida do Carmo Rego M, Farina J, Machado HR: Aplasia cutis congenita of scalp: is there a better treatment strategy? Childs Nerv Syst 22: 1072, 2006 https://doi.org/10.1007/s00381-006-0074-y
  2. Burkhead A, Poindexter G, Morrell DS: A case of extensive aplasia cutis congenita with underlying skull defect and central nervous system malformation: discussion of large skin defects, complications, treatment and outcome. J Perinatol 29: 582, 2009 https://doi.org/10.1038/jp.2008.250
  3. Gravante G, DElogu D, Giordan N, Morano G, Montone A, Esposito G: The use of hyalomatrix PA in the treatment of deep partial-thickness burns. J Burn Care Res 28: 269, 2007 https://doi.org/10.1097/BCR.0B013E318031A236
  4. Myers SR, Partha VN, Soranzo C, Price RD, Navsaria HA: Hyalomatrix: a temporary epidermal barrier, hyaluronan delivery, and neodermis induction system for keratinocyte stem cell therapy. Tissue Eng 13: 2733, 2007 https://doi.org/10.1089/ten.2007.0109
  5. Bilginer B, Onal MB, Bahardir S, Akalan N: Aplasia cutis congenital of the scalp, skull and dura associated with adams-oliver syndrome. Turk Neurosurg 18: 191, 2008
  6. Silva JC, Almeida JP, Serra S, Faquini I, Quinino S, Magalhaes FN, Azevedo-Filho H: Aplasia cutis congenita of the scalp. Arq Neuropsiquiatr 66: 752, 2008 https://doi.org/10.1590/S0004-282X2008000500030
  7. Casanova D, Amar E, Bardot J, Magalon G: Aplasia cutis congenita. report on 5 family cases involving the scalp. Eur J Pediatr Surg 11: 280, 2001 https://doi.org/10.1055/s-2001-17158
  8. Dutra LB, Pereira MD, Kreniski TM, Zanon N, Cavalheiro S, Ferreira LM: Aplasia cutis congenital: management of a large skull defect with acrania. J Craniofac Surg 20: 1288, 2009 https://doi.org/10.1097/SCS.0b013e3181ae2108